Mode
Text Size
Log in / Sign up

TBP expansion in SCA17 can cause dementia-like symptoms and requires etiological reconsiderationNew Diagnosis for Dementia Patients with Spinocerebellar Ataxia Type 17

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider etiological reconsideration and genetic testing for TBP expansion in patients with dementia-first presentations.

This case report and focused literature review examines a proband with Spinocerebellar ataxia type 17 (SCA17) who presented with symptoms initially suggestive of dementia. The authors also conducted a review of 25 published studies to characterize the clinical landscape of SCA17.

The primary finding is that the proband was confirmed to have SCA17 with TBP alleles of 37/51 repeats, and an asymptomatic relative was identified with the same expanded 51-repeat allele. The review of 25 studies highlights significant phenotypic heterogeneity in SCA17, including variations in age at onset, TBP repeat size, and presenting syndromes such as cognition-dominant, behavior-dominant, or Huntington disease-like presentations.

A noted limitation is that the case-based perspective is not intended to serve as validated clinical criteria. However, the findings support etiological reconsideration for patients with dementia-first presentations who may have underlying genetic conditions like SCA17. Clinical utility lies in recognizing the diverse ways TBP expansion can manifest clinically.

How this fits prior evidence

This report addresses a gap in identifying specific genetic causes of dementia-like symptoms. While prior coverage notes that advanced imaging and blood-based biomarkers are transforming the diagnosis and management of ADRD, this case highlights how molecular assessment for TBP expansions can provide definitive diagnostic redirection in cases with high phenotypic heterogeneity.

Doctors are looking closer at patients first diagnosed with dementia. In a recent case report and review of 25 studies, researchers found that some people presenting with memory loss actually have a genetic condition called spinocerebellar ataxia type 17 (SCA17). This finding is important because the symptoms can look very similar to common forms of dementia.

The study followed one person and their relative. The individual was initially thought to have dementia but was later confirmed to have SCA17 caused by a specific genetic expansion. Testing also identified the same genetic marker in an asymptomatic family member. This highlights how important it is to check for underlying genetic causes when symptoms first appear.

Because this study is based on a single case and a small review of 25 other cases, the results are not yet enough to change standard medical rules. However, it suggests that doctors should consider different possibilities when a patient shows early signs of cognitive decline. You should talk with your doctor about how these findings might apply to specific symptoms.

What this means for you:
Some dementia-like symptoms may actually be caused by a genetic condition called spinocerebellar ataxia type 17.

Common questions

What is spinocerebellar ataxia type 17?

Spinocerebellar ataxia type 17 (SCA17) is a genetic condition. In this study, it was identified by specific TBP alleles. It can cause symptoms that look like dementia or other neurological issues. Because the symptoms vary widely, it can be hard to distinguish from other conditions without proper testing.

How does SCA17 differ from typical dementia?

While both can involve memory loss and cognitive decline, SCA17 is a specific genetic condition. The study of 25 cases showed that SCA17 patients have wide variations in symptoms, including behavior changes or movements that look like Huntington disease. This means a more specific diagnosis might be needed for some people.

Is this finding enough to change how dementia is treated?

This study is a case report and literature review, not a large-scale clinical trial. It is not intended to serve as validated clinical criteria yet. However, it suggests that doctors should consider looking for genetic causes like SCA17 when a patient first shows signs of cognitive decline.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
BackgroundSpinocerebellar ataxia type 17 (SCA17) is an autosomal dominant repeat-expansion disorder with marked phenotypic heterogeneity. Cognitive and neuropsychiatric symptoms may dominate early recognition and initially suggest a primary dementia syndrome. We aimed to illustrate diagnostic redirection in dementia-first SCA17 through integrated clinical, imaging, familial, and molecular assessment.Case presentationWe describe the clinical course, neurological findings, cognitive and functional assessments, ancillary investigations, neuroimaging, pedigree information, and molecular genetic findings of a proband with SCA17 and one tested at-risk adult relative. To contextualize the family, we conducted a focused literature review of genetically confirmed SCA17 case and family reports identified through PubMed, Web of Science, Embase, China National Knowledge Infrastructure (CNKI), and Wanfang up to April 16, 2026.FindingsRepeat-expansion testing established SCA17 in a proband who had initially presented through a dementia-first clinical pathway, with TATA-box binding protein (TBP) alleles of 37/51 repeats. Targeted presymptomatic cascade testing identified the same expanded 51-repeat allele in her asymptomatic adult daughter. Review of 25 published studies showed broad variation in age at onset, TBP repeat size, family context, presenting syndrome, and cumulative phenotype, including cognition-dominant, behavior-dominant, Huntington disease-like, parkinsonian, dystonic, choreic, seizure-associated, and atypical neuroimaging presentations.ConclusionThe present family illustrates a dementia-first route to SCA17 recognition, in which the initial syndrome-based dementia interpretation remained etiologically provisional as cerebellar signs, cerebellar-predominant atrophy, autosomal-dominant family context, and TBP expansion were integrated. This case-based perspective is intended to support etiological reconsideration in selected dementia-first presentations, rather than to serve as validated clinical criteria.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.